Tops & Flops Stocks
| Security | Change (%) | 1w ▼ | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Oncotherapy Science Inc. | -6.590% | -13.265% | -19.048% | -60.648% | -34.615% | -90.286% | -91.210% |
| Vitrolife AB | 1.400% | -13.346% | -19.166% | -31.569% | -21.308% | - | - |
| Glycomimetics Inc. | -2.360% | -14.404% | -48.122% | 17.504% | -35.841% | -29.612% | - |
| Poxel S.A. | 3.950% | -14.595% | 26.148% | 0.158% | 17.037% | -90.395% | -91.247% |
| Oncopeptides AB | 2.970% | -15.397% | -53.674% | -73.032% | -62.468% | - | - |
| CONMED Corp. | -4.170% | -15.441% | -22.297% | -49.115% | -43.069% | -49.115% | -21.448% |
| Oncimmune Holdings PLC | 0.820% | -16.892% | 7.895% | -41.706% | -7.519% | -90.160% | -75.400% |
| X4 Pharmaceuticals, Inc. | -3.030% | -19.010% | -17.520% | -24.191% | 32.179% | - | - |
| Carmat | -3.480% | -19.499% | -25.850% | -64.269% | -55.074% | - | - |
| Fate Therapeutics Inc. | -0.060% | -21.037% | -47.838% | -33.000% | -0.253% | -94.992% | - |
| India Globalization Capital | 0.570% | -21.239% | 8.537% | 29.927% | 35.878% | -72.824% | -74.407% |
| SELLAS Life Sciences Group Inc | -15.740% | -21.359% | 21.674% | -13.830% | 16.308% | -82.766% | -99.691% |
| Medigene AG | -2.300% | -24.346% | -31.840% | -18.820% | -9.119% | -65.636% | -83.727% |
| Prana Biotechnology Ltd. | - | -25.000% | 50.000% | -78.571% | -25.000% | -91.176% | -92.500% |
| Evotec SE ADR | 5.130% | -26.617% | -32.690% | -48.632% | -54.393% | - | - |
| Bone Therapeutics S.A. | 7.500% | -27.119% | -39.437% | -88.624% | -89.250% | -99.663% | -99.767% |
| Evotec SE | 3.850% | -29.343% | -33.880% | -41.879% | -54.682% | -71.403% | -56.377% |
| Sanai Health Industry Group Co. Ltd. | -50.000% | -50.000% | -75.000% | -92.308% | -90.000% | -93.333% | -97.917% |
| Abeona Therapeutics Inc. | 4.580% | -53.669% | -51.940% | 14.754% | -31.635% | -90.673% | - |